The difference in survival between Mdm2+/+Arf+/+p53−/− and Mdm2+/+Arf−/−p53−/− mice was significant (p = 0.0011, log-rank test), suggesting loss of Arf cooperated with deletion of p53 to decrease tumor latency. Here, CDKN2A is linked to neoplasm.